Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model
Keywords: Neurodegeneration; Neurodegenerative disorders; PACAP; Dopaminergic neuron survival; SH-SY5Y neuroblastoma cell survival; Vasodilation; Cq; quantification cycle; Eu3; europium(III) cryptate; MPP+; 1-methyl-4-phenylpyridinium; MPTP; 1-methyl-4-phenyl-1,2,3